Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 59 (CCDC59) is a protein-coding gene product localized mainly in the nucleoplasm[6]. It enables RNA binding and participates as a component of transcription complexes involved in the regulation of pulmonary surfactant-associated proteins SFTPB and SFTPC, where it enhances homeobox protein Nkx-2.1-activated promoter activities[7][2]. Diseases associated with CCDC59 include intracystic papillary adenoma and tinea favosa[2]. It is not established as a therapeutic target (receptor, enzyme, transporter, etc.), nor are there known drugs or biomarker uses for patient selection or safety concerns linked to CCDC59.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 59 (CCDC59).